Rethinking antioxidants in the intensive care unit

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 11, 2013, Pages 1283-1285

  Jain, Manu ^a   Chandel, Navdeep S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; DNA; GLUTAMINE; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 18; LIPID; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOL; SELENIUM; SUPEROXIDE; TOLL LIKE RECEPTOR; ZINC ION;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIOXIDANT ACTIVITY; BLOOD LEVEL; CELL ACTIVITY; CELL DAMAGE; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; CELL STRESS; CRITICALLY ILL PATIENT; CYTOKINE STORM; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; DRUG TREATMENT FAILURE; ENTERAL DRUG ADMINISTRATION; HOMEOSTASIS AND REGULATION; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTRACELLULAR SIGNALING; LYMPHOCYTE; MITOCHONDRION; MONOCYTE; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SELENIUM BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SUPPLEMENTATION; VENTILATED PATIENT; VITAMIN SUPPLEMENTATION;

EID: 84890016460     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1380CP     Document Type: Review

References (31)

1. Szakmany T, Hauser B, Radermacher P. N-acetylcysteine for sepsis and systemic inflammatory response in adults. Cochrane Database Syst Rev 2012;9:CD006616.
2. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG. Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013;368:1489-1497.
3. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 2008;45:1-17.
4. Rhee S. Cell signaling: H2O2, a necessary evil for cell signaling. Science 2006;312:1882-1883.
5. Finkel T. From sulfenylation to sulfhydration: what a thiolate needs to tolerate. Sci Signal 2012;5:pe10.
6. Murphy MP. Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxid Redox Signal 2012;16:476-495.
7. Brand M. The sites and topology of mitochondrial superoxide production. Exp Gerontol 2010;45:466-472.
8. Lambeth JD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189.
9. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012;48:158-167.
10. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009;47:1239-1253.
11. Hekimi S, Lapointe J, Wen Y. Taking a "good" look at free radicals in the aging process. Trends Cell Biol 2011;21:569-576.
12. Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002;30:1782-1786.
13. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986;1:11-14.
14. Sznajder JI, Fraiman A, Hall JB, Sanders W, Schmidt G, Crawford G, Nahum A, Factor P, Wood LD. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989;96:606-612.
15. Bowler RP, Velsor LW, Duda B, Chan ED, Abraham E, Ware LB, Matthay MA, Day BJ. Pulmonary edema fluid antioxidants are depressed in acute lung injury. Crit Care Med 2003;31:2309-2315.
16. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996;24:1179-1183.
17. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004;CD004477.
18. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 2000;28:3799-3807.
19. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE. A trial of antioxidants n-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997;112:164-172.
20. Ortolani O, Conti A, De Gaudio AR, Masoni M, Novelli G. Protective effects of n-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock 2000;13:14-18.
21. Laurent T, Markert M, Feihl F, Schaller MD, Perret C. Oxidant-antioxidant balance in granulocytes during ARDS: effect of n-acetylcysteine. Chest 1996;109:163-166.
22. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, DonahoeM, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27:1409-1420.
23. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997;23:768-774.
24. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999;27:1807-1813.
25. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-857.
26. Segal BH, GrimmMJ, Khan AN, HanW, Blackwell TS. Regulation of innate immunity by NADPH oxidase. Free Radic Biol Med 2012;53:72-80.
27. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity 2013;38:633-643.
28. West AP, Shadel GS, Ghosh S.Mitochondria in innate immune responses. Nat Rev Immunol 2011;11:389-402.
29. Tschopp J, Schroder K. Nlrp3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 2010;10:210-215.
30. Sena LA, Li S, Jairaman A, PrakriyaM, Ezponda T, Hildeman DA,Wang CR, Schumacker PT, Licht JD, Perlman H, et al. Mitochondria are required for antigen-specific t cell activation through reactive oxygen species signaling. Immunity 2013;38:225-236.
31. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-268.